Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients.
BACKGROUND: Campath 1H is a depleting, humanized anti-CD52 monoclonal antibody that has now been used in 31 renal allograft recipients. The results have been very encouraging and are presented herein. METHODS: Campath 1H was administered, intravenously, in a dose of 20 mg, on day 0 and day 1 after...
المؤلفون الرئيسيون: | Calne, R, Moffatt, S, Friend, P, Jamieson, N, Bradley, J, Hale, G, Firth, J, Smith, K, Waldmann, H |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
1999
|
مواد مشابهة
-
Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients.
حسب: Calne, R, وآخرون
منشور في: (1998) -
Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five years.
حسب: Watson, C, وآخرون
منشور في: (2005) -
Reversal of allograft rejection using the monoclonal antibody, Campath-1G.
حسب: Friend, P, وآخرون
منشور في: (1991) -
CAMPATH-IH in multiple sclerosis.
حسب: Moreau, T, وآخرون
منشور في: (1996) -
Campath 1H (alemtuzumab) in renal transplantation: 5-year comparative follow up.
حسب: Watson, C, وآخرون
منشور في: (2004)